The present invention features methods for selecting a patient with an enhanced therapeutic response to a botulinum toxin treatment of a headache. In some embodiments, the methods comprise the step of identifying a patient who is not using a prophylactic headache pain medication, a patient who is overusing an acute pain medication, a patient who suffers four or more hours of headache pain per headache, a patient who has a chronic daily headache for twenty or more years, and/or a patient who has twenty or more headache days out of a 30-day-month.

 
Web www.patentalert.com

< Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling

< Method of screening for a compound using guanosine triphosphate (GTP)-binding protein-coupled receptor protein, BG37

> PRO polypeptides for diagnosis of systemic lupus erythematosis

> Methods compositions and articles of manufacture for modulating bone growth

~ 00602